Keyphrases
Acute Leukemia
33%
Acute Lymphoblastic Leukemia
33%
Acute Myeloid Leukemia
100%
Allogeneic Hematopoietic Stem Cell Transplantation (allo-HSCT)
30%
BCP-ALL
20%
Bone Marrow
27%
CD19
41%
CD34+
26%
Cell Population
19%
Cellular Level
16%
Childhood Leukemia
19%
Children with Cancer
28%
Chimeric Antigen Receptor T Cells (CAR-T)
21%
Down Syndrome
17%
Drug Development
17%
Engraftment
30%
Event-free Survival
23%
Ewing Sarcoma Family of Tumors
54%
Flow Cytometric
21%
Fusion Gene
17%
Gene Therapy
21%
Hematopoiesis
18%
Hematopoietic Cells
22%
Hematopoietic Stem Cell Transplantation
25%
High Risk
18%
Immune-deficient Mice
33%
Immunophenotyping
17%
In Vivo Model
18%
Leukemia
66%
Leukemia Patients
32%
Multilineage
16%
Older Adults
24%
Pediatric
39%
Personalized Therapy
17%
Phase II Trial
17%
Positron Emission Tomography-computed Tomography (PET-CT)
16%
Relapsed or Refractory
24%
RNA Sequencing (RNA-seq)
22%
SCID Mice
32%
Severe Combined Immunodeficient Mice
18%
Stem Cell Population
25%
Stem Cell Transplantation
26%
Stem Cells
18%
T Cells
22%
T-cell Acute Lymphoblastic Leukemia (T-ALL)
20%
Total-body PET/CT
16%
Transplantation
19%
Tumor
34%
Tumor Cell Lines
18%
Tumor Cells
25%
Medicine and Dentistry
(3 Iodobenzyl)guanidine
15%
3 Hydroxyephedrine
15%
Acute B-Cell Lymphoblastic Leukemia
15%
Acute Lymphoblastic Leukemia
57%
Acute Myelogenous Leukemia
26%
Acute Myeloid Leukemia
79%
Adolescence
17%
Auer Rod
15%
B Cell
35%
Carbon 11
14%
Cell Population
27%
Central Nervous System
10%
Chemotherapy
16%
Childhood Cancer
27%
Clinical Trial
16%
Dexamethasone
15%
Disease
16%
Down Syndrome
22%
Event Free Survival
15%
Ewing Sarcoma
17%
Experimental Therapy
11%
Hematopoietic Stem Cell Transplantation
24%
Immunity
10%
Immunotherapy
26%
Iodine 123
15%
Leukemia
42%
Leukemia in Children
17%
Malignant Neoplasm
35%
Metastatic Carcinoma
18%
Neoplasm
46%
Normal Stem Cell
15%
Oncology
21%
Pediatric Cancer
18%
Pediatrics
54%
Personalized Medicine
22%
Positron Emission Tomography-Computed Tomography
16%
Precursor
30%
Radioactive Tracer
15%
Receptor
12%
Reduced Intensity Conditioning
12%
RNA Sequence
13%
SCID Mouse
25%
Single Photon Emission Computed Tomography-Computed Tomography
15%
Stem Cell
28%
Stem Cell Therapy
11%
Survival Rate
12%
Sympathetic Nervous System
15%
T Cell
20%
Whole Body PET
16%
Xenograft
25%
Immunology and Microbiology
Adolescence
11%
Allogeneic Stem Cell Transplantation
24%
Antigen Expression
9%
B Cell
57%
Bone Marrow Cell
10%
Bone Marrow Transplantation
8%
CD117
8%
CD11a
10%
CD19
40%
CD34
53%
CD7
9%
Cell Adhesion Proteins
11%
Cell Death
11%
Cell Level
16%
Cell Population
34%
Cell Subpopulation
17%
Central Nervous System
15%
Chimera
15%
Conditioning
10%
Cord Blood Stem Cell Transplantation
9%
Cytokine
27%
Cytokine Receptor
9%
DNA Content
10%
Drug Megadose
9%
Engraftment
26%
Epstein Barr Virus
14%
Event Free Survival
20%
Fusion Gene
9%
Gene Expression
10%
Hematopoiesis
28%
Hematopoietic Cell
22%
High Risk Population
11%
Human Cell
13%
Immunology
13%
Immunotherapy
31%
Innate Lymphoid Cell
9%
Leukemia Cell
12%
Lineages
14%
Myeloid
55%
NOD SCID Mouse
15%
Precursor
43%
SCID Mouse
39%
Stem Cell
56%
Stem Cell Transplantation
16%
Survival Rate
11%
T Cell
32%
T Cell Receptor
8%
Tumor Cell
25%
Tumor Cell Line
16%
Xenograft
11%
